Brind.
  1. The House of Representatives and the Senate are currently operating.
  2. Legislation is awaiting final approval from both the House and the Senate.

House and Senate Advance Healthcare Price Transparency Legislation

2 reports, 2 independent Updated Jul 24
Gone quiet
Reports
2
Developments
4
Repetition
50%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Key committees in the House and Senate are advancing legislation focused on healthcare price transparency requirements. The House Energy and Commerce Committee unanimously advanced H.R. 9393, the Lower Costs, More Transparency Act of 2026, while the Senate Health, Education, Labor, and Pensions Committee approved S. 2355, the Patients Deserve Price Tags Act, by a vote of 21 to 1.

From aei.org

Why it matters

Some supportBrind's analysis of the reports

The effort addresses a long-standing demand for Americans to know the cost of healthcare services, with a survey showing 93% of voters support price transparency. However, hospital and insurance company interests have strongly opposed these measures.

Legislation is awaiting final approval from both the House and the Senate, which are currently operating.

From nevadanewsandviews.com

Who's involved

  • HouseThe House Energy and Commerce Committee advanced H.R. 9393, the Lower Costs, More Transparency Act of 2026.
  • senateThe Senate Health, Education, Labor, and Pensions Committee approved S. 2355, the Patients Deserve Price Tags Act.
  • federal governmentThe federal government is the body through which the proposed regulatory shift is being attempted.
  • MedicareMedicare is potentially impacted by required transparency in healthcare services.

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • MedicareSpeculative

    Medicare might face changes in reimbursement policies due to required price transparency.

How it developed

Newest first. Tap a step to see who reported it.
  1. Lindo provided pricing data to the Commission, while the Chamber of Commerce opposed the Bill's market intervention, and the Senate debated the bill concerning government powers.Sub-event
  2. Congress discussed price controls on September 8, 2026.Sub-event
  3. The Senate committee in Islamabad is questioning OGRA's pricing mechanism for high-speed diesel and petrol, including a briefing on the Reko Diq project.Sub-event
  4. Both chambers are pushing for price transparency legislation.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped